In animal models of T2DM, berberine has been shown to increase the number of beneficial bacteria, reduce potentially pathogenic bacteria, and protect the islets and protect insulin target organs by reducing the invasion of inflammatory cells and inhibiting the development of a systemic inflammatory response (231). The gene discussed is INS; the disease is type 2 diabetes mellitus.